Gennex Laboratories
Gennex Laboratories Share Price Chart
Gennex Laboratories last traded at ₹9.52 (2026-10-13). Over the past month the stock moved -15.1%, three months the stock moved -21.4%, year the stock moved -24.5%. Its closing range over 52 weeks is ₹8.01 – ₹16.43, with the latest close 42.1% below the high.
Closing prices up to 2026-10-13.
About Gennex Laboratories
Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]
Business Overview:[1][2] GLL is an ISO 9001:2008, TUV, ISO 14001 and OSHAS 18000 certified vertically integrated Active Pharmaceutical Ingredient manufacturer & exporter of Bulk Drugs, Intermediates and Biotech Products in the form of Expectorants, Muscle Relaxants, Analgesic and Anti Fungal, etc.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Gennex Laboratories reported sales of ₹39.84 crore (+16.6%) and net profit of ₹4.67 crore (-6.8%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 39.84 | 4.38 | 10.99 | 4.67 | 0.18 |
| Mar 2026 | 60.96 | 5.89 | 9.66 | 4.46 | 0.15 |
| Dec 2025 | 42.96 | 8.57 | 19.95 | 6.00 | 0.22 |
| Sep 2025 | 39.30 | 7.56 | 19.24 | 5.51 | 0.21 |
| Jun 2025 | 34.18 | 5.07 | 14.83 | 5.01 | 0.20 |
| Mar 2025 | 40.33 | 2.02 | 5.01 | 3.07 | 0.10 |
| Dec 2024 | 40.01 | 7.15 | 17.87 | 5.06 | 0.20 |
| Sep 2024 | 33.38 | 7.46 | 22.35 | 5.38 | 0.21 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +83.6% | +87.1% | +13.5% | +20.7% | +17.7% | +7.4% | +51.2% | +16.6% |
| Operating profit growth | +29.3% | +49.0% | -67.7% | +20.1% | +1.3% | +19.9% | +191.6% | -13.6% |
| Net profit growth | +75.2% | +83.3% | -31.8% | +7.5% | +2.4% | +18.6% | +45.3% | -6.8% |
| EPS growth | +23.5% | +33.3% | -50.0% | +5.3% | +0.0% | +10.0% | +50.0% | -10.0% |
| OPM % | 22.4% | 17.9% | 5.0% | 14.8% | 19.2% | 20.0% | 9.7% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Gennex Laboratories reported sales of ₹173.00 crore (+16.9%) and net profit of ₹21.00 crore (+16.7%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 173.00 | 22.00 | 13.00 | 21.00 | 0.76 |
| Mar 2025 | 148.00 | 27.00 | 18.00 | 18.00 | 0.71 |
| Mar 2024 | 87.00 | 17.00 | 20.00 | 13.00 | 0.58 |
| Mar 2023 | 66.00 | 5.00 | 7.00 | 5.00 | 0.28 |
| Mar 2022 | 61.00 | 5.00 | 9.00 | 4.00 | 0.21 |
| Mar 2021 | 60.00 | 7.00 | 11.00 | 4.00 | 0.21 |
| Mar 2020 | 56.00 | 3.00 | 6.00 | 2.00 | 0.10 |
| Mar 2019 | 56.00 | 4.00 | 7.00 | 2.00 | 0.12 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +27.3% | +0.0% | +7.1% | +1.7% | +8.2% | +31.8% | +70.1% | +16.9% |
| Operating profit growth | +100.0% | -25.0% | +133.3% | -28.6% | +0.0% | +240.0% | +58.8% | -18.5% |
| Net profit growth | +100.0% | +0.0% | +100.0% | +0.0% | +25.0% | +160.0% | +38.5% | +16.7% |
| EPS growth | +200.0% | -16.7% | +110.0% | +0.0% | +33.3% | +107.1% | +22.4% | +7.0% |
| OPM % | 7.0% | 6.0% | 11.0% | 9.0% | 7.0% | 20.0% | 18.0% | 13.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Gennex Laboratories.
Get Free AI Stock Analysis FREE →Latest News
No recent news available for Gennex Laboratories.
Frequently Asked Questions
What is the share price of Gennex Laboratories today?
Gennex Laboratories shares were last quoted at ₹9.52 (-0.9% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Gennex Laboratories?
Gennex Laboratories has a price-to-earnings (P/E) ratio of 10.41 and a price-to-book (P/B) ratio of 1.08. The industry P/E is 53.33.
What is the 52-week high and low of Gennex Laboratories?
The 52-week high of Gennex Laboratories is ₹17.25 and the 52-week low is ₹7.05.
What is the market cap of Gennex Laboratories?
The market capitalisation of Gennex Laboratories is about ₹245.38 crore.
How did Gennex Laboratories perform in its latest quarterly results?
In the latest quarter (Jun 2026), Gennex Laboratories reported sales of ₹39.84 crore (+16.6%) and net profit of ₹4.67 crore (-6.8%), compared with the same quarter last year.
Is Gennex Laboratories a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Gennex Laboratories has a 3-year ROE of 10.00%, 3-year profit growth of 57.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Gennex Laboratories?
Promoters hold about 23.63% of Gennex Laboratories.
Which sector does Gennex Laboratories belong to?
Gennex Laboratories belongs to the Pharmaceuticals & Drugs sector.